SAA1 and amyloidosis: With a diagnostic gold standard represented by the kidney biopsy, SAA amyloidosis is associated with a faster progression to an ESKD, leading to increased rates of infection, severe sepsis, and multi-organ system involvement, and thus to reduced patient survival [57].